US case analysis: Myriad at the Supreme Court

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

US case analysis: Myriad at the Supreme Court

Managing IP Correspondent
August 31 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

FeaturesMIP Special FocusLife Sciences 2013 (August 2013)
managing-ip.png
Managing IP Correspondent
Contact
more from across site and SHARED ros bottom lb

More from across our site

Patents
Mergers.jpg
Taylor Wessing in merger talks with US firm Winston & Strawn
The tie-up could result in the firm’s German and France-based teams, which both have strong UPC expertise, becoming independent
December 12 2025
Patents
Dolby Laboratories sign and logo at Silicon Valley campus. Dolby Laboratories company specializing in audio noise reduction and audio encoding, compression
This week on MIP: Dolby sues Acer at UPC | AI platform raises $40m
News of a slowdown in the UK’s clean energy IP landscape and an EPO report on unitary patent uptake were also among the top talking points
December 12 2025
Patents
Reflective skyscrapers, business office buildings.
‘Industry disruptors’: why IP boutiques are gaining a market edge
Price hikes at ‘big law’ firms are pushing some clients toward boutiques that offer predictable fees, specialised expertise, and a model built around prioritising IP
Sanjana Mishra, December 11 2025
Patents
Split.jpg
Weekly take: Why KWM’s demerger was the best bet for both sides
The Australian side, in particular, can benefit by capitalising on its independent status to bring in more work from Western countries while still working with its former Chinese partner
Sukanya Sarkar, December 11 2025
Patents
Koen Johannes.png
Inside Brinkhof and Bardehle’s ‘landmark’ UPC victory
Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently
Max Walters, December 10 2025
SIA25 Winners Announced Graphic (1).png
Winners revealed: celebrating the 2025 Social Impact EMEA winners
View the official winners of the 2025 Social Impact EMEA Awards
Shailyn Tirado, December 10 2025
Trademarks
kingwood.png
King & Wood Mallesons to split, 14 years after union
King & Wood Mallesons will break into two entities, 14 years after a merger between a Chinese and an Australian firm created the combined outfit
Sukanya Sarkar, December 09 2025
Trademarks
Everett, WA USA - circa August 2022: Angled, selective focus on Oatly milk alternative products for sale inside an Albertsons grocery store
UK Supreme Court set for milk trademark showdown
Teams from Shakespeare Martineau and DWF will take centre stage in a dispute concerning the registrability of dairy terminology in plant-based products
Max Walters, December 09 2025
Patents
Senem.JPG
Turkish IP firm founder: how patent ‘claim trees’ can boost efficiency
Senem Kayahan, attorney and founder at PatentSe, discusses how she divides prosecution tasks, and reveals the importance of empathetic client advice
December 09 2025
Patents
Beautiful skyline of Dubai city at night in United Arab Emirates
Exclusive: AIPPI facing boycott threat over Dubai Congress
The association’s Australian group has filed a formal complaint against the choice of venue, citing Dubai as an unsafe environment for the LGBTQIA+ community
Max Walters, December 08 2025
Gift this article